droxidopa has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Dela Peña, I; Shen, G; Shi, WX | 1 |
| Delabar, JM | 1 |
| Augustin, S; Brull, A; Coll, M; Esteban, R; Ezkurdia, N; Genescà, J; Guardia, J; Martell, M; Raurell, I; Rodriguez, S | 1 |
| Brinster, LR; Donsante, A; Goldstein, DS; Kaler, SG; Sullivan, P | 1 |
| Ando, K; Mano, U; Matsui, K; Toyoshima, E | 1 |
| Hirose, Y; Kajita, S; Mizukawa, K; Ogawa, N; Ohara, S; Watanabe, Y | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
1 review(s) available for droxidopa and Disease Models, Animal
| Article | Year |
|---|---|
[New perspectives on molecular and genic therapies in Down syndrome].
Topics: Animals; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Droxidopa; Drug Delivery Systems; Fluoxetine; Forecasting; Gene Expression Regulation; Genetic Association Studies; Genetic Therapy; Hedgehog Proteins; Humans; Memantine; Mice; Mice, Transgenic; Models, Genetic; Neuronal Plasticity; Neurotransmitter Agents; Pentylenetetrazole; Phenotype; Signal Transduction | 2010 |
6 other study(ies) available for droxidopa and Disease Models, Animal
| Article | Year |
|---|---|
Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Benserazide; Delay Discounting; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Droxidopa; Drug Therapy, Combination; Locomotion; Male; Maze Learning; Prefrontal Cortex; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Species Specificity; Ventral Tegmental Area | 2021 |
Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Topics: Animals; Antiparkinson Agents; Bile Ducts; Blood Pressure; Carbidopa; Carbon Tetrachloride; Disease Models, Animal; Diuresis; Droxidopa; Enzyme Inhibitors; Hemodynamics; Hypertension, Portal; Ligation; Liver Cirrhosis; Male; Natriuresis; Nitric Oxide Synthase Type III; Phosphorylation; Portal Vein; Propranolol; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation; rho-Associated Kinases; Signal Transduction; Urodynamics; Vascular Resistance | 2012 |
L-threo-dihydroxyphenylserine corrects neurochemical abnormalities in a Menkes disease mouse model.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphatases; Animals; Antiparkinson Agents; Blood-Brain Barrier; Brain; Brain Chemistry; Cation Transport Proteins; Copper; Copper-Transporting ATPases; Disease Models, Animal; Dopamine; Dopamine beta-Hydroxylase; Droxidopa; Female; Male; Menkes Kinky Hair Syndrome; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Nerve Degeneration; Norepinephrine | 2013 |
[Ataxia in rolling mouse Nagoya and the norepinephrine system--a psychopharmacological study].
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Cerebellar Ataxia; Disease Models, Animal; Droxidopa; Male; Mice; Mice, Mutant Strains; Norepinephrine; Phenoxybenzamine; Propranolol; Thyrotropin-Releasing Hormone | 1982 |
MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dopamine; Droxidopa; Levodopa; Mice; Mice, Inbred C57BL; Parkinson Disease, Secondary; Pyridines; Receptors, Muscarinic; Somatostatin | 1987 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |